Evaluation of Hematological parameters as prognostic indicators in COVID -19 patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- KIMS Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- These parameters are expected to act as indicators of immune status of patient, hyperinflammatory and cytokine storm status, indicators of superinfection , disease severity and extent of systemic inflammation
Study Overview
Brief Summary
The study aims to assess the role of hematological parameters ,both direct and derived, in predicting the severity of COVID 19 patients.The parameters like absolute lymphocyte count,total leukocyte count,absolute neutrophil count, neutrophil lymphocyte ratio,platelet lymphocyte ratio,RDW to total platelet count ratio,mean platelet volume etc will be evaluated in predicting the severity of disease requiring early intervention in COVID 19 patients.These parameters will be correlated with other biochemical and clinical parameters also.
The results obtained in the study will be published in appropriate journals.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 1.00 Year(s) to 80.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •ALL RT-PCR POSITIVE COVID-19 PATIENTS.
Exclusion Criteria
- •All COVID unrelated cases .
- •Patients in which proper clinical details missing.
Outcomes
Primary Outcomes
These parameters are expected to act as indicators of immune status of patient, hyperinflammatory and cytokine storm status, indicators of superinfection , disease severity and extent of systemic inflammation
Time Frame: The parameters will be assessed at the time of admission and at the time of discharge in case of general ward patients and at 1 week interval in case of ICU patients
Secondary Outcomes
- FEW DERIVED HEMATOLOGICAL PARAMETERS CAN ACT AS INDICTORS OF POOR PROGNOSIS IN COVID 19 PATIENTS(Parameters will be assessed at the time of discharge in general ward patients and at 1 week interval in ICU patients)